Alta Partners

Alta Partners
Company typePrivate ownership
IndustryPrivate equity
PredecessorBurr, Egan, Deleage & Co.
Founded1996
Founder
HeadquartersOne Embarcadero Center
San Francisco, California, United States
Key people
  • Daniel S. (Dan) Janney,
    managing partner[1]
  • Peter (Pete) Hudson,
    managing partner[2]
  • Robert J. (Bob) More,
    managing partner[3]
ProductsVenture capital
Websitewww.altapartners.com

Alta Partners is a venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.[4]

Cofounder Guy Nohra later relocated in Barcelona, Spain, to cofound Alta Life Sciences[5] in 2016.[6]

History

[edit]

Dan Janney joined Alta as a partner in 1996, when the firm was founded; Pete Hudson and Bob More joined in 2017.[7]

In 2000, the firm launched two VC funds, Alta California Partners III and Alta BioPharma Partners II.[8] It raised its ninth fund, Alta Partners NextGen Fund I, in 2017.[7] Two new healthcare VC funds were launched in 2004: Alta BioPharma Partners III and ACP IV.[9]

In May 2022, the company filed a lawsuit against BRC Inc.[10] (NYSE:BRCC),[11] the surviving entity of a 2021 merger between SilverBox Capital and Black Rifle Coffee[12]) in the Southern District of New York, which alleging a breach of contract, and seeking damages due to BRC's refusal to allow Alta to exercise warrants in 2022. The suit was settled in June 2025, with Alta paying BRC $1,000,000, and BRC issuing 2,300,100 shares of its Class A common stock to Alta.[11]

Investments

[edit]

Notable investments have included Ellie Mae, Be Inc., Ilex Oncology, Connects Corp, The Medicines Co.,[8] Kite Pharmaceuticals, ZS Pharma, Esperion, Allakos Chemgenx, DeCode Calistoga, Aerie, Cymabay, Tyra Biosciences,[13] DIspatchHealth and VIR Biotechnology.[4]

See also

[edit]

References

[edit]
  1. ^ "Daniel S. Janney - ALLK | Allakos Inc. - Wall Street Journal". www.wsj.com. Retrieved 2025-07-16.
  2. ^ "Dr. Peter Hudson "Pete"". Bloomberg. Retrieved July 16, 2025.
  3. ^ "Robert J More "Bob"". Bloomberg. Retrieved July 16, 2025.
  4. ^ a b "16 Top Biotech VC Firms 2025 | TRUiC". startupsavant.com. 2024-07-02. Retrieved 2025-07-15.
  5. ^ "Guy Nohra, Alta Life Sciences: "Barcelona has world-class science that needs to be invested in"". catalonia.com. Retrieved 2025-07-17.
  6. ^ "Alta Life Sciences Portfolio Investments, Alta Life Sciences Funds, Alta Life Sciences Exits". www.cbinsights.com. Retrieved 2025-07-17.
  7. ^ a b Hale, Conor (2018-06-13). "Alta raises $130M for its new biotech VC fund, missing its $200M goal | Fierce Biotech". www.fiercebiotech.com. Retrieved 2025-07-17.
  8. ^ a b Writer, Staff (2000-06-01). "Alta Launches Two New Funds -". Venture Capital Journal. Retrieved 2025-07-17.
  9. ^ Archives, L. A. Times (2004-03-31). "Alta Partners Healthcare Funds Exceed Targets". Los Angeles Times. Retrieved 2025-07-17.
  10. ^ "Alta Partners, LLC v. BRC Inc". Justia Dockets & Filings. Retrieved 2025-07-15.
  11. ^ a b "BRC Settles Lawsuit with Alta Partners". TipRanks. June 20, 2025. Retrieved 2025-07-15.
  12. ^ "TANG CAPITAL PARTNERS LP v. BRC INC (2024)". Findlaw. Retrieved 2025-07-15.
  13. ^ "Carlsbad's Tyra Biosciences nets $50 million to combat drug resistance in cancer therapies". San Diego Union-Tribune. 2020-01-21. Retrieved 2020-04-23.
[edit]